Digital Look

Welcome to Digital Look++,
you are not logged in

RUA Life Sciences (RUA)

Health Care

15.50p

Trade now with Barclays Stockbrokers

Select chart: EPS | Dividend | Revenue

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Mar-21	1.53	(1.59)	(8.20)p	n/a	n/a	n/a	n/a	0.0%
31-Mar-22	1.62	(2.36)	(9.32)p	n/a	n/a	n/a	n/a	0.0%
31-Mar-23	2.18	(2.32)	(9.03)p	n/a	n/a	n/a	n/a	0.0%
31-Mar-24	2.19	(2.02)	(4.29)p	n/a	n/a	n/a	n/a	0.0%
31-Mar-25	4.11	(0.01)	n/a	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
30-Sep-25	4.70	(1.20)	(1.80)p	n/a	n/a	n/a	n/a	0.0%
30-Sep-26	5.20	(0.10)	(0.40)p	n/a	n/a	n/a	n/a	0.0%

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	n/a	n/a	n/a	0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

Find out about IFRS and how this affects the financial infomation for all UK companies.